However, data from clinical trials conducted to date indicate that TERT-based therapeutic vaccination has limited anticancer effects: various immunogens have been reported to induce T-cell responses to TERT in cancer patients, but this effect is usually insufficient to control the growth of the tumor. This evidence concerns the gene TERT and neoplasm.